Monotherapy with anti-LFA-1 monoclonal antibody promotes long-term survival of rat islet xenografts

Cell Transplantation

Volumn 17, Issue 6, 2008, Pages 599-608

  Tredget, Eric B ^a   Arefanian, Hossein ^a   Gill, Ronald G ^b   Rajotte, Ray V ^a   Rayat, Gina R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

Islet transplantation; Leukocyte function associated antigen 1 (LFA 1); Rapamycin (sirolimus); Rat islets; Type 1 diabetes mellitus (T1DM); Xenograft

Indexed keywords

CD11B ANTIGEN; GLUCOSE; LEUKOCYTE FUNCTION ASSOCIATED ANTIGEN 1 MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; RAPAMYCIN; STREPTOZOCIN; UNCLASSIFIED DRUG; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELL ISOLATION; CELL PROLIFERATION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY CAPSULE; LYMPHOCYTE; MACROPHAGE; MALE; MONONUCLEAR CELL; MONOTHERAPY; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RAT; SHORT COURSE THERAPY; SPLEEN CELL; STREPTOZOCIN DIABETES; T LYMPHOCYTE SUBPOPULATION; XENOGRAFT; ANIMAL; IMMUNOLOGY; PANCREAS ISLET; PATHOLOGY; TRANSPLANTATION; WISTAR FURTH RAT;

MUS; RATTUS; SUS;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL PROLIFERATION; GRAFT ENHANCEMENT, IMMUNOLOGIC; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MALE; MICE; MICE, INBRED BALB C; RATS; RATS, INBRED WF; SIROLIMUS; TRANSPLANTATION, HETEROLOGOUS;

EID: 53749102330     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368908786092757     Document Type: Article

References (35)

1. Almond, P. S.; Moss, A.; Nakhleh, R. E.; Melin, M.; Chen, S.; Salazar, A.; Shirabe, K.; Matas, A. J. Rapamycin: Immunosuppression, hyporesponsiveness, and side effects in a porcine renal allograft model. Transplantation 56:275-281; 1993.
2. Andres, A.; Toso, C.; Morel, P.; Bosco, D.; Bucher, P.; Oberholzer, J.; Mathe, Z.; Mai, G.; Wekerle, T.; Berney, T.; Buhler, L. H. Macrophage depletion prolongs discordant but not concordant islet xenograft survival. Transplantation 79:543-549; 2005.
3. Appel, M. C.; Banuelos, S. J.; Greiner, D. L.; Shultz, L. D.; Mordes, J. P.; Rossini, A. A. Prolonged survival of neonatal porcine islet xenografts in mice treated with a donor-specific transfusion and anti-CD154 antibody. Transplantation 77:1341-1349; 2004.
4. Arai, K.; Sunamura, M.; Wada, Y.; Takahashi, M.; Kobari, M.; Kato, K.; Yagita, H.; Okumura, K.; Matsuno, S. Preventing effect of anti-ICAM-1 and anti-LFA-1 monoclonal antibodies on murine islet allograft rejection. Int. J. Pancreatol. 26:23-31; 1999.
5. Asnaghi, L.; Bruno, P.; Priulla, M.; Nicolin, A. mTOR: A protein kinase switching between life and death. Pharmacol. Res. 50:545-549; 2004.
6. Blaha, P.; Bigenzahn, S.; Koporc, Z.; Schmid, M.; Langer, F.; Selzer, E.; Bergmeister, H.; Wrba, F.; Kurtz, J.; Kiss, C.; Roth, E.; Muehlbacher, F.; Sykes, M.; Wekerle, T. The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade. Blood 101:2886-2893; 2003.
7. Fabien, N.; Bergerot, I.; Orgiazzi, J.; Thivolet, C. Lymphocyte function associated antigen-1, integrin alpha 4, and L-selectin mediate T-cell homing to the pancreas in the model of adoptive transfer of diabetes in NOD mice. Diabetes 45:1181-1186; 1996.
8. Garrett, Jr., H. E.; Duvall-Seaman, D.; Helsley, B.; Groshart, K. Treatment of vascular rejection with rituximab in cardiac transplantation. J. Heart Lung Transplant. 24:1337-1342; 2005.
9. Inoki, K.; Ouyang, H.; Li, Y.; Guan, K. L. Signaling by target of rapamycin proteins in cell growth control. Microbiol. Mol. Biol. Rev. 69:79-100; 2005.
10. Kin, T.; Korbutt, G. S.; Kobayashi, T.; Dufour, J. M.; Rajotte, R. V. Reversal of diabetes in pancreatectomized pigs after transplantation of neonatal porcine islets. Diabetes 54:1032-1039; 2005.
11. Kneteman, N. M.; Cattral, M. C.; Warnock, G. L.; Scharp, D. W.; Jaspan, J. L.; Rajotte, R. V. Immunosuppression and pancreatic islet transplantation. Horm. Metab Res. Suppl. 25:193-199; 1990.
12. Korbutt, G. S.; Elliott, J. F.; Ao, Z.; Smith, D. K.; Warnock, G. L.; Rajotte, R. V. Large scale isolation, growth, and function of porcine neonatal islet cells. J. Clin. Invest. 97:2119-2129; 1996.
13. Kwon, G.; Marshall, C. A.; Pappan, K. L.; Remedi, M. S.; McDaniel, M. L. Signaling elements involved in the metabolic regulation of mTOR by nutrients, incretins, and growth factors in islets. Diabetes 53(Suppl. 3):S225-S232; 2004.
14. Larsson, L. C.; Corbascio, M.; Widner, H.; Pearson, T. C.; Larsen, C. P.; Ekberg, H. Simultaneous inhibition of B7 and LFA-1 signaling prevents rejection of discordant neural xenografts in mice lacking CD40L. Xenotransplantation 9:68-76; 2002.
15. Lebwohl, M.; Tyring, S. K.; Hamilton, T. K.; Toth, D.; Glazer, S.; Tawfik, N. H.; Walicke, P.; Dummer, W.; Wang, X.; Garovoy, M. R.; Pariser, D. A novel targeted T-cell modulator, efalizumab, for plaque psoriasis. N. Engl. J. Med. 349:2004-2013; 2003.
16. Nicolls, M. R.; Coulombe, M.; Beilke, J.; Gelhaus, H. C.; Gill, R. G. CD4-dependent generation of dominant transplantation tolerance induced by simultaneous perturbation of CD154 and LFA-1 pathways. J. Immunol. 169:4831-4839; 2002.
17. Nicolls, M. R.; Coulombe, M.; Yang, H.; Bolwerk, A.; Gill, R. G. Anti-LFA-1 therapy induces long-term islet allograft acceptance in the absence of IFN-gamma or IL-4. J. Immunol. 164:3627-3634; 2000.
18. Nicolls, M. R.; Gill, R. G. LFA-1 (CD11a) as a therapeutic target. Am. J. Transplant. 6:27-36; 2006.
19. Olack, B. J.; Jaramillo, A.; Benshoff, N. D.; Kaleem, Z.; Swanson, C. J.; Lowell, J. A.; Mohanakumar, T. Rejection of porcine islet xenografts mediated by CD4+ T cells activated through the indirect antigen recognition pathway. Xenotransplantation 9:393-401; 2002.
20. Perez, O. D.; Mitchell, D.; Jager, G. C.; South, S.; Murriel, C.; McBride, J.; Herzenberg, L. A.; Kinoshita, S.; Nolan, G. P. Leukocyte functional antigen 1 lowers T cell activation thresholds and signaling through cytohesin-1 and Jun-activating binding protein 1. Nat. Immunol. 4:1083-1092; 2003.
21. Rayat, G. R.; Gill, R. G. Indefinite survival of neonatal porcine islet xenografts by simultaneous targeting of LFA-1 and CD154 or CD45RB. Diabetes 54:443-451; 2005.
22. Rayat, G. R.; Johnson, Z. A.; Beilke, J. N.; Korbutt, G. S.; Rajotte, R. V.; Gill, R. G. The degree of phylogenetic disparity of islet grafts dictates the reliance on indirect CD4 T-cell antigen recognition for rejection. Diabetes 52:1433-1440; 2003.
23. Rayat, G. R.; Korbutt, G. S.; Elliott, J. F.; Rajotte, R. V. Survival and function of syngeneic rat islet grafts placed within the thymus versus under the kidney capsule. Cell Transplant. 6:597-602; 1997.
24. Rosenberg, P. B.; Vriesendorp, A. E.; Drazner, M. H.; Dries, D. L.; Kaiser, P. A.; Hynan, L. S.; Dimaio, J. M.; Meyer, D.; Ring, W. S.; Yancy, C. W. Induction therapy with basiliximab allows delayed initiation of cyclosporine and preserves renal function after cardiac transplantation. J. Heart Lung Transplant. 24:1327-1331; 2005.
25. Rossi, J. F.; Fegueux, N.; Lu, Z. Y.; Legouffe, E.; Exbrayat, C.; Bozonnat, M. C.; Navarro, R.; Lopez, E.; Quit-tet, P.; Daures, J. P.; Rouille, V.; Kanouni, T.; Widjenes, J.; Klein, B. Optimizing the use of anti-interleukin-6 monoclonal antibody with dexamethasone and 140 mg/m2 of melphalan in multiple myeloma: results of a pilot study including biological aspects. Bone Marrow Transplant. 36:771-779; 2005.
26. Rowinsky, E. K. Targeting the molecular target of rapamycin (mTOR). Curr. Opin. Oncol. 16:564-575; 2004.
27. Ryan, E. A.; Paty, B. W.; Senior, P. A.; Bigam, D.; Alfadhli, E.; Kneteman, N. M.; Lakey, J. R.; Shapiro, A. M. Five-year follow-up after clinical islet transplantation. Diabetes 54:2060-2069; 2005.
28. Ryan, E. A.; Paty, B. W.; Senior, P. A.; Shapiro, A. M. Risks and side effects of islet transplantation. Curr. Diabetes Rep. 4:304-309; 2004.
29. Schneider, H.; Valk, E.; da Rocha, D. S.; Wei, B.; Rudd, C. E. CTLA-4 up-regulation of lymphocyte function-associated antigen 1 adhesion and clustering as an alternate basis for coreceptor function. Proc. Natl. Acad. Sci. USA 102:12861-12866; 2005.
30. Segundo, D. S.; Ruiz, J. C.; Izquierdo, M.; Fernandez-Fresnedo, G.; Gomez-Alamillo, C.; Merino, R.; Benito, M. J.; Cacho, E.; Rodrigo, E.; Palomar, R.; Lopez-Hoyos, M.; Arias, M. Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients. Transplantation 82:550-557; 2006.
31. Shapiro, A. M.; Lakey, J. R.; Ryan, E. A.; Korbutt, G. S.; Toth, E.; Warnock, G. L.; Kneteman, N. M.; Rajotte, R. V. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343:230-238; 2000.
32. Singh, N. P.; Guo, L.; Que, X.; Shirwan, H. Blockade of indirect recognition mediated by CD4+ T cells leads to prolonged cardiac xenograft survival. Xenotransplantation 11:33-42; 2004.
33. Takahashi, K.; Rooney, A. P.; Nei, M. Origins and divergence times of mammalian class II MHC gene clusters. J. Hered. 91:198-204; 2000.
34. Watson, C. J.; Bradley, J. A.; Friend, P. J.; Firth, J.; Taylor, C. J.; Bradley, J. R.; Smith, K. G.; Thiru, S.; Jamieson, N. V.; Hale, G.; Waldmann, H.; Calne, R. Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation - efficacy and safety at five years. Am. J. Transplant. 5:1347-1353; 2005.
35. Wu, G.; Pfeiffer, S.; Schroder, C.; Zhang, T.; Nguyen, B. N.; Lea, W.; Kelishadi, S.; Atkinson, J. B.; Schuurman, H. J.; White, D. J.; Azimzadeh, A. M.; Pierson, III, R. N. Co-stimulation blockade targeting CD154 and CD28/B7 modulates the induced antibody response after a pig-to-baboon cardiac xenograft. Xenotransplantation 12:197-208; 2005.